Clinical Trial Update: Lentiviral FIX Gene Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a lentiviral FIX gene therapy for Hemophilia B is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Lentiviral FIX Gene Therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Hemophilia B | Phase 1 | Status: RECRUITING